Projects per year
Organization profile
Organisation profile
The focus of the Laboratory for Molecular and Cellular Therapy (LMCT) is directed towards the application of basic immunological knowledge and molecular biotechnology for the understanding, diagnosis and treatment of human diseases, including cancer, infectious disease and brain disease.
Keywords
- immunology
- cancer
- Infection
- brain disease
Fingerprint
Dive into the research topics where https://lmct.research.vub.be/ is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Dorien Autaers
- Vrije Universiteit Brussel
- https://lmct.research.vub.be/
- Basic (bio-) Medical Sciences - Education/Research Officer
Person: Researcher, Administrative/technical staff
-
Robin Maximilian Awad
- Vrije Universiteit Brussel
- https://lmct.research.vub.be/
- Basic (bio-) Medical Sciences - doctoral student
- Faculty of Medicine and Pharmacy
Person: Researcher, PhD
-
Jonathan Bastos
- Vrije Universiteit Brussel
- Faculty of Medicine and Pharmacy
- https://lmct.research.vub.be/
- Basic (bio-) Medical Sciences - Doctoral scholarschip
Person: Researcher, PhD
-
Thomas Benoot
- Vrije Universiteit Brussel
- Basic (bio-) Medical Sciences - Doctoral scholarschip, Academic
- Faculty of Medicine and Pharmacy
- https://lmct.research.vub.be/
Person: Researcher, PhD
-
Sanne Bevers
- Vrije Universiteit Brussel
- https://lmct.research.vub.be/
- Basic (bio-) Medical Sciences - Academic, Undefined
- Faculty of Medicine and Pharmacy
Person: Researcher, PhD
-
IOFPOC55: PoC project ROTEA-DC Implementing the RoteaTM technology in dendritic cell manufacturing
15/07/22 → 14/07/23
Project: Applied
-
IOF3013: GEAR: Brussels Liver Research to Valorisation Alliance (B-Liver): Valorisation of VUB’s liver cell biology and toxicology expertise via a consortium focused on liver therapeutics, patient and consumer safety.
Vanhaecke, T., van Grunsven, L., De Kock, J., Vinken, M. & Reynaert, H.
1/01/20 → 31/12/24
Project: Applied
Research output
-
Challenges in neoantigen-directed therapeutics
Lybaert, L., Lefever, S., Fant, B., Smits, E., De Geest, B., Breckpot, K., Dirix, L., Feldman, S. A., van Criekinge, W., Thielemans, K., van der Burg, S. H., Ott, P. A. & Bogaert, C., 9 Jan 2023, In: Cancer Cell. 41, 1, p. 15-40 26 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile7 Downloads (Pure) -
Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targeting
Erreni, M., D'Autilia, F., Avigni, R., Bolli, E., Arnouk, S. M., Movahedi, K., Debie, P., Anselmo, A., Parente, R., Vincke, C., van Leeuwen, F. W. B., Allavena, P., Garlanda, C., Mantovani, A., Doni, A., Hernot, S. & Van Ginderachter, J. A., 1 Jan 2023, In: Theranostics. 13, 1, p. 355-373 19 p.Research output: Contribution to journal › Article › peer-review
-
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma
Fan, R., Satilmis, H., Vandewalle, N., Verheye, E., Vlummens, P., Maes, A., Muylaert, C., De Bruyne, E., Menu, E., Evans, H., Chantry, A., De Beule, N., Hose, D., Töngren, M., Eriksson, H., Vanderkerken, K., Maes, K., Breckpot, K. & De Veirman, K., 17 Jan 2023, In: Journal for ImmunoTherapy Of Cancer. 11, 1, e005319.Research output: Contribution to journal › Article › peer-review
-
Viral clade is associated with severity of symptomatic genotype 3 Hepatitis E virus infections in Belgium, 2010-2018
Belgian Association for the Study of the Liver, Peeters, M., Schenk, J., De Somer, T., Roskams, T., Locus, T., Klamer, S., Subissi, L., Suin, V., Delwaide, J., Stärkel, P., De Maeght, S., Willems, P., Colle, I., Van Hoof, M., Van Acker, J., Van Steenkiste, C., Moreno, C., Janssens, F., Reynders, M. & 25 others, , Jan 2023, In: Journal of Hepatology. 78, 1, p. 67-77 11 p.Research output: Contribution to journal › Article › peer-review
-
A combination of ontogeny and environment drives macrophage identity across brain regions
Van Hove, H., 2022, Brussel: Crazy Copy Center Productions. 187 p.Research output: Thesis › PhD Thesis
Activities
-
Selection Committee - Grant Writing Officer (fac. GF) (Event)
Karine Breckpot (Member)
9 Feb 2022Activity: Membership › Work on academic committees and working groups
-
Combining Immunohistochemistry and Gene Expression Analysis to Refine Scoring
Karine Breckpot (Speaker)
20 Sep 2022 → 21 Sep 2022Activity: Talk or presentation › Talk or presentation at a conference
File -
Granted Project Scientific Fund Willy Gepts: Development of a nanoCAR-T cell approach for the treatment of multiple myeloma
Heleen Hanssens (Supervisor), Nick Devoogdt (Supervisor) & Karine Breckpot (Supervisor)
1 Jan 2022 → 1 Jan 2026Activity: Other
-
Granted Project Scientific Fund Willy Gepts: Personalized mRNA cancer therapy: Validation and Vaccination
Wout De Mey (Recipient) & Karine Breckpot (Supervisor)
1 Jan 2022 → 1 Jan 2023Activity: Other
-
Preclinical validation of [18F]-FB-(Anti Human PD-L1) Nanobody for PET imaging
Herlinde Dierick (Speaker), Karine Breckpot (Contributor), Nick Devoogdt (Contributor), Marleen Keyaerts (Contributor), Vicky Caveliers (Contributor), Tony Lahoutte (Contributor) & Jessica Bridoux (Contributor)
7 May 2022Activity: Talk or presentation › Talk or presentation at a conference